News NICE to reassess Pfizer blood cancer drug Company successfully appealed against rejection last summer
News Pfizer facing NICE showdown over leukaemia drug Pfizer locks horns with NICE following EU approval.
News NICE backs Amgen's Blincyto in rare leukaemia Drug will also be available to children via Cancer Drugs Fund.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
